54973-0232 NDC - ARNISPORT (ARNICA MONTANA, HYPERICUM PERFORATUM, RUTA GRAVEOLENS FLOWERING TOP, LEDUM PALUSTRE TWIG, BELLIS PERENNIS, CALCIUM FLUORIDE, TRIBASIC CALCIUM PHOSPHATE, CALCIUM SULFATE ANHYDROUS, FERROSOFERRIC PHOSPHATE, POTASSIUM CHLORIDE, POTASSIUM PHOSPHATE, DIBASIC, POTASSIUM SULFATE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE, SODIUM SULFATE, AND SILICON DIOXIDE)

Drug Information

Product NDC: 54973-0232

Proprietary Name: ARNISPORT

Non Proprietary Name: arnica montana, hypericum perforatum, ruta graveolens flowering top, ledum palustre twig, bellis perennis, calcium fluoride, tribasic calcium phosphate, calcium sulfate anhydrous, ferrosoferric phosphate, potassium chloride, potassium phosphate, dibasic, potassium sulfate, magnesium phosphate, dibasic trihydrate, sodium chloride, sodium phosphate, dibasic, heptahydrate, sodium sulfate, and silicon dioxide

Active Ingredient(s):
  • 30 [hp_X]/1 ARNICA MONTANA;
  • 6 [hp_X]/1 BELLIS PERENNIS;
  • 6 [hp_X]/1 CALCIUM FLUORIDE;
  • 3 [hp_X]/1 CALCIUM SULFATE ANHYDROUS;
  • 3 [hp_X]/1 FERRUM PHOSPHORICUM;
  • 6 [hp_X]/1 HYPERICUM PERFORATUM;
  • 6 [hp_X]/1 LEDUM PALUSTRE TWIG;
  • 3 [hp_X]/1 MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE;
  • 3 [hp_X]/1 POTASSIUM CHLORIDE;
  • 3 [hp_X]/1 POTASSIUM PHOSPHATE, DIBASIC;
  • 3 [hp_X]/1 POTASSIUM SULFATE;
  • 6 [hp_X]/1 RUTA GRAVEOLENS FLOWERING TOP;
  • 6 [hp_X]/1 SILICON DIOXIDE;
  • 6 [hp_X]/1 SODIUM CHLORIDE;
  • 3 [hp_X]/1 SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE;
  • 3 [hp_X]/1 SODIUM SULFATE;
  • 3 [hp_X]/1 TRIBASIC CALCIUM PHOSPHATE


Administration Route(s): ORAL

Dosage Form(s): TABLET, SOLUBLE

Pharmacy Class(es):
  • Blood Coagulation Factor [EPC];
  • Calcium [CS];
  • Calculi Dissolution Agent [EPC];
  • Cations;
  • Divalent [CS];
  • Increased Coagulation Factor Activity [PE];
  • Increased Large Intestinal Motility [PE];
  • Increased Large Intestinal Motility [PE];
  • Increased Large Intestinal Motility [PE];
  • Increased Large Intestinal Motility [PE];
  • Increased Large Intestinal Motility [PE];
  • Increased Large Intestinal Motility [PE];
  • Increased Large Intestinal Motility [PE];
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
  • Inhibition Small Intestine Fluid/Electrolyte Absorption [PE];
  • Magnesium Ion Exchange Activity [MoA];
  • Osmotic Activity [MoA];
  • Osmotic Activity [MoA];
  • Osmotic Activity [MoA];
  • Osmotic Activity [MoA];
  • Osmotic Activity [MoA];
  • Osmotic Activity [MoA];
  • Osmotic Activity [MoA];
  • Osmotic Laxative [EPC];
  • Osmotic Laxative [EPC];
  • Osmotic Laxative [EPC];
  • Osmotic Laxative [EPC];
  • Osmotic Laxative [EPC];
  • Osmotic Laxative [EPC];
  • Osmotic Laxative [EPC];
  • Potassium Compounds [CS];
  • Potassium Compounds [CS];
  • Potassium Compounds [CS];
  • Potassium Salt [EPC];
  • Potassium Salt [EPC];
  • Potassium Salt [EPC];
  • Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Labeler Information

Labeler Name: Hyland's Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:4/28/2000

Package Information

No. Package Code Package Description Billing Unit
154973-0232-150 TABLET, SOLUBLE in 1 BOTTLE, PLASTIC (54973-0232-1)
254973-0232-24 TABLET, SOLUBLE in 1 POUCH (54973-0232-2)
354973-0232-34 POUCH in 1 CARTON (54973-0232-3) / 4 TABLET, SOLUBLE in 1 POUCH

NDC Record

Field Name Field Value Definition
PRODUCT NDC54973-0232The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEARNISPORTThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEarnica montana, hypericum perforatum, ruta graveolens flowering top, ledum palustre twig, bellis perennis, calcium fluoride, tribasic calcium phosphate, calcium sulfate anhydrous, ferrosoferric phosphate, potassium chloride, potassium phosphate, dibasic, potassium sulfate, magnesium phosphate, dibasic trihydrate, sodium chloride, sodium phosphate, dibasic, heptahydrate, sodium sulfate, and silicon dioxideThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMETABLET, SOLUBLEThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE4/28/2000This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEHyland's Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEARNICA MONTANA; BELLIS PERENNIS; CALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; FERRUM PHOSPHORICUM; HYPERICUM PERFORATUM; LEDUM PALUSTRE TWIG; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM SULFATE; RUTA GRAVEOLENS FLOWERING TOP; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; TRIBASIC CALCIUM PHOSPHATEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH30; 6; 6; 3; 3; 6; 6; 3; 3; 3; 3; 6; 6; 6; 3; 3; 3 
ACTIVE INGRED UNIT[hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1 
PHARM CLASSESBlood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023